Axsome Therapeutics (AXSM) Profit After Tax (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Axsome Therapeutics | 11.82 Bn | 11.51 Bn | 176.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -126.00% |
| Dec 31, 2025 | 39.53% |
| Sep 30, 2025 | 1.55% |
| Jun 30, 2025 | 19.26% |
| Mar 31, 2025 | 20.69% |
| Dec 31, 2024 | -15.96% |
| Sep 30, 2024 | 18.58% |
| Jun 30, 2024 | -16.07% |
| Mar 31, 2024 | 30.71% |
| Dec 31, 2023 | -58.61% |
| Sep 30, 2023 | 7.40% |
| Jun 30, 2023 | -498.77% |
| Mar 31, 2023 | 81.68% |
| Dec 31, 2022 | -36.63% |
| Sep 30, 2022 | -8.17% |
| Jun 30, 2022 | -4.56% |
| Mar 31, 2022 | -16.65% |
| Dec 31, 2021 | 2.60% |
| Sep 30, 2021 | -8.05% |
| Jun 30, 2021 | -10.34% |
| Mar 31, 2021 | -0.33% |
| Dec 31, 2020 | -27.22% |
| Sep 30, 2020 | -25.09% |
| Jun 30, 2020 | 43.58% |
| Mar 31, 2020 | -30.95% |
| Dec 31, 2019 | -29.64% |
| Sep 30, 2019 | -39.04% |
| Jun 30, 2019 | -29.34% |
| Mar 31, 2019 | -10.87% |
| Dec 31, 2018 | -15.88% |
| Sep 30, 2018 | -0.01% |
| Jun 30, 2018 | -72.32% |
| Mar 31, 2018 | 35.33% |
| Dec 31, 2017 | -15.50% |
| Sep 30, 2017 | 9.19% |
| Jun 30, 2017 | 11.39% |
| Mar 31, 2017 | -9.09% |
| Dec 31, 2016 | -1.87% |
| Sep 30, 2016 | -5.61% |
| Jun 30, 2016 | -16.13% |
| Mar 31, 2016 | -74.33% |
| Dec 31, 2015 | 26.47% |
| Sep 30, 2015 | -114.90% |
| Jun 30, 2015 | 0.50% |